PEER REVIEW

Detecting and Treating Glaucoma in a Myopic Patient Without High IOP
By Robert Chang, MD, and Kuldev Singh, MD, MPH
THERAPEUTICS UPDATE
Revisiting Risk
It is time to take a fresh look at carbonic anhydrase inhibitors and sulfonamide allergy.
By Jeff Martow, MDCM, FRCSC; Evan Martow, BMSc, MDCM; and Mattan Lustgarten, BSc
INTERNATIONAL PERSPECTIVES
The Eyes of Africa Project
Partners bring comprehensive eye care to rural Malawi.
By William Eric Sponsel, MD
COVER FOCUS:
Diagnostic Testing
The Future Is Now
The era of 24-hour IOP monitoring is upon us.
By Kaweh Mansouri, MD, MPH
Assessing Corneal Biomechanics
The importance of these properties rests primarily with their effects on IOP measurement.
By Leon W. Herndon, MD
Evaluating Quality of Life in Glaucoma
Understand the impact of the disease to improve care.
By Felipe A. Medeiros, MD, PhD
The Next Step in Visual Fields
Home testing procedures and real-world, task-related performance methods are needed.
By Chris A. Johnson, PhD, DSc
Do We Need Perimetry?
As glaucoma advances, visual field testing provides valuable insight.
By Murray Fingeret, OD
Enhancing Visual Field Testing
Techniques to increase the value and reliability of visual fields.
By Oluwatosin Smith, MD
Visual Fields as Screening Tools
Problems remain, but this form of testing allows physicians to accurately assess glaucoma’s impact on patients’ vision.
By Jeffrey D. Henderer, MD

Pitfalls in Optical Coherence Tomography Imaging
Essentials for correct interpretation.
By Sanjay Asrani, MD

Where Does Ganglion Cell Analysis Fit?
The role of macular optical coherence tomography in glaucoma assessment.
By Hiroshi Ishikawa, MD
The Role of Optic Nerve Head Imaging
Past, present, and future.
By Anitra Turner, MD, and Anjali Bhorade, MD, MSCI

RNFL Analysis in the Diagnosis of Glaucoma
Measuring peripapillary retinal nerve fiber layer thickness with spectral-domain optical coherence tomography provides an objective and reliable estimate of glaucomatous optic nerve damage.
By Luis E. Vazquez, MD, PhD, and Linda Y. Huang, MD

Optical Coherence Tomography as a Glaucoma Screening Tool
Does it affect glaucoma detection in the community?
By Lisa F. Rosenberg, MD, and Casey Cahill, MD
Is There Still a Role for Optic Disc Photography?
New is not necessarily better.
By George L. Spaeth, MD; Kamran Rahmatnejad, MD; and Lichuan Zeng, BSE
The Promise of Genetic Testing
Research may improve the diagnosis and treatment of glaucoma.
By John Fingert, MD, PhD
PRACTICE POINTERS
Down, But Not Out: How the AAO Has Responded to Medicare's 2016 Ophthalmology Fee Cuts
Faced with cuts to ophthalmic reimbursements, the American Academy of Ophthalmology sprang into action.